About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
https://www.weizmann-usa.org/news-media/news-releases/celebrating-excellence/
Nov 09, 2021...
REHOVOT, ISRAEL—November 9, 2021—The Weizmann Institute of Science bestowed honorary PhDs upon seven individuals on Monday, Nov. 8, in recognition of their career and personal achievements. The degrees were presented during a ceremony held in-person and broadcast virtually as part of the 73rd Annual General Meeting of the International Board.
Weizmann Institute President Prof. Alon Chen congratulated and conferred the degrees on the honorees, who participated in the ceremony both in person in the Michael Sela Auditorium on the Weizmann campus, and from their homes around the world. The hybrid nature of the event echoed the “borderless” theme selected for this year’s International Board events.
https://www.weizmann-usa.org/news-media/feature-stories/weizmann-tops-2021-leiden-ranking-again/
Dec 06, 2021...
For the second year in a row, the Weizmann Institute of Science was ranked amongst the world’s top ten research institutions!
Specifically, the Institute was ranked eighth for research quality by the Centre for Science and Technology Studies (CWTS) of Leiden University, the Netherlands (“Leiden Ranking”). It is also one of only two institutions outside the United States in the top ten (the other is the École Polytechnique Fédérale de Lausanne (EPFL), Switzerland, ranking ninth). Other institutions in the top ten include Harvard, Stanford, Princeton, Berkeley, Rockefeller, MIT, and Caltech.
https://www.weizmann-usa.org/news-media/video-gallery/creating-new-knowledge-for-everyone/
Dec 21, 2021... The Vera and Chaim Weizmann Honor Society closed out 2021 with a virtual event for Honor Society members with updates on The Institute’s remarkable achievements of the past year, and to preview some exciting projects on the horizon.
May 28, 2022...
Michael Sela, a world-renowned Israeli immunology expert who also served as president of the Weizmann Institute of Science, died on Friday at the age of 98.
An Israel Prize laureate at the age of 35 for his life science research who also earned many other awards during his career, Sela was involved in the development of the drug Copaxone for the treatment of multiple sclerosis as well as three cancer treatment drugs. His research shed light on the genetic aspects of the functioning of the immune system and led to new fields of immunology.
Jun 03, 2022...
In the late 1960s, as a researcher at the Weizmann Institute of Science, Prof. Sela wanted to shed light on the causes and nature of the potentially disabling disease. He and two colleagues—Ruth Arnon and Dvora Teitelbaum—injected synthetic proteins into lab animals in an attempt to induce something akin to multiple sclerosis as part of that quest.
To their surprise, none of the laboratory animals developed the malady. “We wanted to cause disease, and we were unsuccessful,” Prof. Sela later told TheMarker, an Israeli newspaper.
Jul 18, 2022...
Homo sapiens has come to dominate the planet, but what are the traits that have allowed humans to have such a position? On this episode, “Human Story,” Dr. Liat Ben David, CEO of the Davidson Institute of Science Education, the educational arm of Israel's acclaimed Weizmann Institute of Science, discusses her book, The Story of Our Lives, The: Homo Sapiens' Secrets of Success.
Excerpt from Groks Science Show"I do have strong beliefs that through the education processes such as we’re doing at Davidson with youths — from not only Israel but all over the world — creating and developing science literacy as the tools for making decisions and solving problems for more and more of our youngsters, and if we want the bright future that I’m talking about, science literacy is the pillar of building up a better, democratic, and tolerant society.” – Dr. Liat Ben David
©2022 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR